This company has been marked as potentially delisted and may not be actively trading. RVL Pharmaceuticals (RVLP) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock RVLP Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Unravel Biosciences Receives FDA Orphan Drug Designation for Vorinostat (RVL-001) as a Treatment for Rett SyndromeMay 28, 2024 | tmcnet.comRaval ICS Ltd.May 17, 2024 | wsj.comRVLPQ RVL Pharmaceuticals plcMarch 2, 2024 | seekingalpha.comRVL Pharmaceuticals PLC RVLPQJanuary 11, 2024 | morningstar.comMRVL Pharmaceuticals Shares Plummet 50% as Subsidiaries File For BankruptcyOctober 13, 2023 | marketwatch.comSpecialty Pharma Firm RVL Pharmaceuticals Subsidiaries File for BankruptcyOctober 12, 2023 | benzinga.comRVL Subsidiaries To Effectuate Change Of Control; RVLP Ordinary Shares Expected To Be CancelledOctober 12, 2023 | markets.businessinsider.comRVL Pharmaceuticals Subsidiaries File for BankruptcyOctober 12, 2023 | finance.yahoo.comWhy Is RVL Pharmaceuticals (RVLP) Stock Up 28% Today?October 6, 2023 | investorplace.comUnmasking the Value Trap: A Deep Dive into RVL Pharmaceuticals PLCAugust 23, 2023 | finance.yahoo.comRVL Pharmaceuticals plc to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceAugust 23, 2023 | finance.yahoo.comRVL Pharmaceuticals (RVLP) Gets a Buy from H.C. WainwrightAugust 21, 2023 | markets.businessinsider.comCrude Oil Falls Sharply; RVL Pharmaceuticals Shares PlummetAugust 16, 2023 | benzinga.comRVLP: Second Quarter ResultsAugust 16, 2023 | msn.comRVL Pharmaceuticals Shares Hit New Lows After Stock Sale >RVLPAugust 16, 2023 | marketwatch.comRVL Pharmaceuticals shares fall after pricing $5M stock offeringAugust 16, 2023 | msn.comDowngrade: Here's How Analysts See RVL Pharmaceuticals plc (NASDAQ:RVLP) Performing In The Near TermAugust 16, 2023 | finance.yahoo.comRVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesAugust 16, 2023 | finance.yahoo.comQ2 2023 RVL Pharmaceuticals PLC Earnings CallAugust 15, 2023 | finance.yahoo.comRVLP: Revenue Dip Prompts Spending ReversalAugust 14, 2023 | msn.comRVL Pharmaceuticals plc Reports Second Quarter 2023 Financial Results; Provides Update on Strategic Business ReviewAugust 14, 2023 | finance.yahoo.comInsiders Re-Evaluate Their US$1.6m Stock Purchase As RVL Pharmaceuticals Falls To US$43mJuly 20, 2023 | finance.yahoo.comRVL Pharma (NASDAQ:RVLP) Rises on Mulling A Strategic TransactionJuly 5, 2023 | msn.comRVL Pharmaceuticals shares are trading higher after the company said it has been considering certain strategic alternatives.July 5, 2023 | benzinga.comRVL Pharmaceuticals plc Announces Result of Proposal to Approve a Waiver of Offer Obligations under Rule 9 of the Irish Takeover Rules at Annual General MeetingJune 15, 2023 | finance.yahoo.comShareholders in RVL Pharmaceuticals (NASDAQ:RVLP) are in the red if they invested three years agoJune 2, 2023 | finance.yahoo.comTime To Worry? Analysts Just Downgraded Their RVL Pharmaceuticals plc (NASDAQ:RVLP) OutlookMay 13, 2023 | finance.yahoo.comRVLP: First Quarter ResultsMay 12, 2023 | finance.yahoo.comRVL Pharmaceuticals: Q1 Earnings InsightsMay 12, 2023 | msn.comQ1 2023 RVL Pharmaceuticals PLC Earnings CallMay 12, 2023 | finance.yahoo.comEarnings Preview: RVL PharmaceuticalsMay 10, 2023 | msn.comRVLP: Selected for NewBeauty AwardMay 1, 2023 | finance.yahoo.comBarclays Sticks to Their Buy Rating for RVL Pharmaceuticals (RVLP)May 1, 2023 | markets.businessinsider.comRVL Pharmaceuticals Stock (NASDAQ:RVLP), DividendsApril 26, 2023 | benzinga.comInvestors Aren't Entirely Convinced By RVL Pharmaceuticals plc's (NASDAQ:RVLP) RevenuesApril 17, 2023 | finance.yahoo.comRVL Pharmaceuticals plc (NASDAQ:RVLP) Short Interest UpdateApril 16, 2023 | marketbeat.comRVL Pharmaceuticals plcApril 9, 2023 | thestreet.comRVL Pharmaceuticals Announces that Upneeq(R) Wins "Best Eye Drop for Drooping Lids" NewBeauty in 13th Annual Beauty AwardsApril 4, 2023 | marketwatch.comRVL Pharmaceuticals Announces that Upneeq® Wins “Best Eye Drop for Drooping Lids” NewBeauty in 13th Annual Beauty AwardsApril 3, 2023 | finance.yahoo.comShould You Hold RVL Pharmaceuticals plc (RVLP) for a Potential Upside?March 24, 2023 | finance.yahoo.comFY2023 EPS Estimates for RVL Pharmaceuticals plc Increased by Analyst (NASDAQ:RVLP)March 23, 2023 | marketbeat.comRVL Pharmaceuticals plc (NASDAQ:RVLP) Q4 2022 Earnings Call TranscriptMarch 22, 2023 | finance.yahoo.comRVL Pharmaceuticals plc - Ordinary Shares's Return On Capital Employed InsightsMarch 21, 2023 | msn.comH.C. Wainwright Sticks to Their Buy Rating for RVL Pharmaceuticals (RVLP)March 21, 2023 | markets.businessinsider.comRVLP: Telemedicine & E-commerce to Drive 2H:23 GrowthMarch 21, 2023 | finance.yahoo.comQ4 2022 RVL Pharmaceuticals PLC Earnings CallMarch 21, 2023 | finance.yahoo.comEarnings Outlook For RVL Pharmaceuticals plc - Ordinary SharesMarch 17, 2023 | benzinga.comWorth Venture Partners LLC Takes Position in RVL Pharmaceuticals plc (NASDAQ:RVLP)February 24, 2023 | marketbeat.comPrivate equity firms account for 39% of RVL Pharmaceuticals plc's (NASDAQ:RVLP) ownership, while private companies account for 24%February 23, 2023 | finance.yahoo.comRVLP: Year Closes on a Strong NoteFebruary 3, 2023 | finance.yahoo.com Get RVL Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RVLP and its competitors with MarketBeat's FREE daily newsletter. Email Address RVLP Media Mentions By Week RVLP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RVLP News Sentiment▼0.000.99▲Average Medical News Sentiment RVLP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RVLP Articles This Week▼00▲RVLP Articles Average Week Get RVL Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RVLP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SXTPW News Today ACONW News Today AIMDW News Today DRTSW News Today AONC News Today BIAFW News Today BBLGW News Today BCTXW News Today BTSGU News Today BFRGW News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RVLP) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RVL Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share RVL Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.